Similar Papers

Paper Title
Journal
Date
Author
What Can We Learn From Clinical Trials of Exon Skipping for DMD?
Qi-Long Lu ... Sebahattin Cirak
Molecular Therapy - Nucleic Acids | VOL. 3
Qi-Long Lu, et. al.Qi-Long Lu ... Sebahattin Cirak
01 Jan 2014
Steroid Treatment for Cardiac Function in Duchenne Muscular Dystrophy
AAP Grand Rounds | VOL. 15
01 May 2006
Genetic Complementation of Human Muscle Cells via Directed Stem Cell Fusion
Manuel Afv Gonçalves ... Antoine Af De Vries
Molecular Therapy | VOL. 16
Manuel Afv Gonçalves, et. al.Manuel Afv Gonçalves ... Antoine Af De Vries
01 Apr 2008
PCR51 Reassessing the Acceptability of Risk of Death Associated With Gene Therapy for Duchenne Muscular Dystrophy: A Qualitative Study to Inform Updating a Quantitative Instrument
H Peay ... M Mcniff
Value in Health | VOL. 25
H Peay, et. al.H Peay ... M Mcniff
01 Dec 2022
View more papers

More From: Neuromuscular Disorders

Paper Title
Journal
Date
Author
Neurogenic arthrogryposis, hypotonia, dysmorphic features plus malformation of cortical development further expands the ARL6IP1 loss-of-function phenotype
Göknur Haliloğlu ... Carsten G Bönnemann
Neuromuscular Disorders | VOL. -
Göknur Haliloğlu, et. al.Göknur Haliloğlu ... Carsten G Bönnemann
01 Feb 2025
CMT2 and distal hereditary motor neuropathy associated with VRK1 variants: case series
Sasha A Živković ... Daniel Dicapua
Neuromuscular Disorders | VOL. 47
Sasha A Živković, et. al.Sasha A Živković ... Daniel Dicapua
01 Feb 2025
Bone Mineral Density Changes in Patients on Drug Therapy for Spinal Muscular Atrophy
Abdelrahman Osman ... Eileen Broomall
Neuromuscular Disorders | VOL. -
Abdelrahman Osman, et. al.Abdelrahman Osman ... Eileen Broomall
01 Feb 2025
Motor Function Testing Rates and Outcomes in Duchenne Muscular Dystrophy with Comorbid Autism and Attention-Deficit/Hyperactivity Disorder
Dennis Keselman ... Susan E Matesanz
Neuromuscular Disorders | VOL. -
Dennis Keselman, et. al.Dennis Keselman ... Susan E Matesanz
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.